The present disclosure generally relates to a medical device, and more particularly to an isolation unit capable of creating a negative pressure environment within a temporary enclosed space. The isolation unit may be used to enclose and isolate the space and air contained therein around the upper body and head of a patient (for example, a patient infected with a respiratory disease), withdraw the air and any airborne and aerosolized viral particles that may have originated from the patient within the enclosed space and remove such particles from the air prior to expelling the air to the surrounding environment.
Aerosol generating medical procedures (AGMP's), such as intubation, CPAP, BiPAP, and high flow oxygen therapy pose a significant threat to healthcare workers during the COVID-19 pandemic. These procedures produce aerosolized viral particles, which dramatically increase the risk of infection for any hospital staff in the room while the procedure is taking place. Due to the high-risk nature of these procedures, they are now banned or performed in a severely limited capacity in hospitals world-wide. Often these procedures are performed in a modified capacity designed to reduce staff exposure and these modified procedures carry a higher patient mortality rate than their full-capacity counterparts while still carrying significant risk to any caregiver that performs them in this limited fashion. Unfortunately, AGMP's are necessary for severe COVID-19 patients who often develop Acute Respiratory Distress Syndrome (ARDS). ARDS patients cannot ventilate without mechanical assistance, and getting that assistance requires hospital staff to undergo an AGMP.
To protect healthcare workers during AGMP's, several groups have developed products, colloquially known as intubation hoods or intubation boxes, which act as a barrier between hospital staff and the patient. Intubation boxes function on the level of personal protective equipment, which is the least effective method of hazard control as defined by the Occupational Safety and Health Administration (OSHA). These hoods are almost invariably made from clear polycarbonate panels with cut-outs for patient access. Relying on proper sealing to minimize the loss of aerosolized viral particles from the spaces they enclose, intubation boxes feature no system to remove or filter the contaminated air. In essence, these devices function as a splatter guard against large droplets only and do not contain aerosolized particles. Intubation hoods may actually increase the risk of infection for healthcare staff through a false sense of security. Additionally, some of these devices have been postulated to focus the generated aerosols through openings and towards medical staff in a concentrated stream. Hospital boards may incorrectly assume that these hoods offer patient isolation and may begin to permit their staff to perform AGMP's in a less limited or full capacity because of this assumption. Indeed, several of these hoods are marketed using statements like “granting safe access to patient airways” and “keeping both parties safe from germs and contaminants spread through medical procedures.” As these hoods are not perfectly sealed and offer no method of removing aerosolized viral particles from the space they enclose, they carry a significant risk of contamination to the healthcare worker through leakage. Thus, performing any AGMP in a less limited capacity than currently allowed for while using an intubation hood will likely increase, not decrease, the risk of hospital staff contracting COVID-19. Most other strategies to mitigate risks are non-disposable, non-adjustable, neutral pressure, and have a limited scope.
Examples of known systems capable of isolating a patient include, for example, the systems described in:
The present disclosure provides a portable isolation unit designed to generate negative pressure inside a small, enclosed space surrounding a patient's head, neck, and shoulders via a combined fan/high-efficiency filter system, the enclosed space and fan/filter system each connected to a duct or similar air pathway so that the fan/filter system is in fluid communication with the enclosed space and the air contained therein. The isolation unit is designed specifically to contain airborne and aerosolized viral particles originating from the patient that are in the air within the enclosed space and the fan/filter system is designed to remove such viral particles before expelling the air to the surrounding environment. Thus, the isolation unit allows various procedures to take place on the patient while it is in use, and multiple healthcare providers can perform these procedures while being protected from any exhaled droplets and aerosols from the patient.
The isolation unit generally includes: a frame and an open-bottomed cover which fits around the frame, the frame and cover forming an enclosed space when placed on the patient to surround the patient's head, neck and shoulders; a duct; a duct connection system; and, a fan/filter system in fluid communication with the enclosed space and configured to: create a negative pressure within the enclosed space to withdraw air contained in enclosed space and into the fan/filter system; remove aerosols or droplets originating from the patient that are contained in the withdrawn air to form clean air; and expel the clean air to the surrounding environment.
The following terms shall have the following meanings:
The term “comprising” and derivatives thereof are not intended to exclude the presence of any additional component, step or procedure, whether or not the same is disclosed herein. In contrast, the term, “consisting essentially of” if appearing herein, excludes from the scope of any succeeding recitation any other component, step or procedure, except those that are not essential to operability and the term “consisting of”, if used, excludes any component, step or procedure not specifically delineated or listed. The term “or”, unless stated otherwise, refers to the listed members individually as well as in any combination.
The articles “a” and “an” are used herein to refer to one or to more than one (i.e. to at least one) of the grammatical objects of the article. The phrases “in one embodiment”, “according to one embodiment” and the like generally mean the particular feature, structure, or characteristic following the phrase is included in at least one embodiment of the present disclosure, and may be included in more than one embodiment of the present disclosure. Importantly, such phrases do not necessarily refer to the same aspect. If the specification states a component or feature “may”, “can”, “could”, or “might” be included or have a characteristic, that particular component or feature is not required to be included or have the characteristic.
The term “duct” is used herein to refer to any enclosed pathway suitable for transferring air or other gases, including, but not limited to, flexible ductwork, hard ductwork, flexible tubing, hard tubing, or pipe.
The term “enclosed space” refers to a contained space formed by frame 1 and cover 2 and which can surround the head, neck and shoulders of a patient during use of the isolation unit and therefore contains the air within the contained space and any aerosols or droplets which have originated or originate from the patient's respiratory system.
The term “proximal” refers to the side closest to the patient's head while the term “distal” refers to the side closest to the patient's shoulders or torso.
The term “use case” refers to any situation in which the isolation unit may potentially be used, such as, but not limited to, intubation (both using a laryngoscope and a GlideScope), extubation, tracheostomy, and even some cases of user error such as when the enclosure is partially lifted off of the bed (to an approximate height of 1″).
The term “portable” refers to a device, machine or the like that can be relatively easily moved from one position to another. This is opposed to a device, machine or the like that is fixed or secured to a stationary object or that weighs enough that it requires a number of people to move it from one place to another.
With reference to
According to one embodiment, the isolation unit 10 is configured to operate in a negative isolation mode and is used to protect uninfected persons in the immediate vicinity from a patient infected with a respiratory disease. In particular, as shown in
With reference now to
With continued reference to
The cover 2 further includes drape 3 attached to the distal wall 22. The drape 3 is sized and configured to be moveable and to seal the enclosed space from the outside environment.
With reference to
With continued reference to
With reference now to
In one embodiment, the fan/filter system 6 includes a vacuum motor (not shown) configured to create high flow negative pressure inside of the enclosed space and to withdraw air from within the enclosed space. The fan/filter system 6 may also include a microbial and/or bacterial filter (for e.g. a HEPA filter, not shown) which is well known in the art and readily available from a large number of suppliers of products for the medical field and which is sized and configured to remove contaminants from the withdrawn air to form clean air before it is expelled through the outlet of the fan/filter system 6 to the surrounding environment. In one embodiment, the fan/filter system 6 is configured to produce at least a −2.5 pressure differential or at least a CSA guideline of −7.5 Pa pressure differential in the enclosed space relative to the outside space to create patient isolation in a variety of use cases for the purpose of protecting healthcare providers from harmful aerosolized or airborne viral particles originating from the patient. In such an embodiment, the fan/filter system 6 provides an air change rate of 2000 air changes per hour, thus changing the air within the enclosed space more than a Class 1 cleanroom. The fan/filter system 6 is also configured to reduce interference with laminar air flows in the room where the isolation unit 10 has been placed, and may include a plurality of outlets having large openings to minimize the velocity of cleaned air as it exits the fan/filter system 6. In still another embodiment, the fan/filter system 6 includes wheels for easy transportation and portability. The fan/filter system 6 may be made of any suitable material so as to be re-usable, as well as long-lasting. The fan/filter system 6 may also be configured to minimize noise emitted from the system to reduce noise disturbance to healthcare providers in the surrounding environment.
The fan/filter system 6 also includes an electrical connection which may be plugged into any standard 120V wall outlet, or into a battery system to turn the fan/filter system 6 on and activate the vacuum motor, allowing the isolation unit 10 to be operable in nearly any location.
With reference to
The isolation unit 10 can generally be operated by placing the frame 1 and open-bottomed cover 2 over the patient's head, neck and shoulders or torso to form an enclosed space around the patient's respiratory system, sealing the distal end of the cover 2 by closing drape 3, connecting the front end of duct 5 to the connector of the frame 1 via the duct connection system 7, connecting the back end of duct 5 to the inlet of fan/filter system 6, turning the fan/filter system 6 on to create a negative pressure inside the enclosed space thereby withdrawing air contained within the enclosed space through the duct 5 and inlet of the fan/filter system 6, passing the air through a filter placed within the fan/filter system 6 and expelling the air through the outlet of the fan/filter system 6 to the surrounding environment.
Thus, in yet another embodiment there is provided a method for operating the isolation unit in a negative isolation mode to protect uninfected persons from a patient infected with a respiratory disease including: (i) placing the frame 1 and open-bottomed cover 2 of the isolation unit 10 over the head, neck and shoulders of the patient to form an enclosed space around the head, neck and shoulders of the patient, (ii) attaching the front end of the duct 5 to the connector 9 of the frame 1 via duct connection system 7, (iii) connecting the back end of duct 5 to the inlet of the fan/filter system 6, (iv) turning the fan/filter system 6 on to activate the vacuum motor of the fan/filter system 6 to create a negative pressure within the enclosed space to withdraw contaminated air contained within the enclosed space such that it passes through the duct 5 and into the inlet of the fan/filter system 6, the contaminated air including contaminants such as virus-contaminated aerosols or droplets originating from the patient, (v) passing the contaminated air through a filter placed within the fan/filter system 6 to remove the contaminants from the contaminated air to form clean air, and (vi) expelling the clean air through the outlet of the fan/filter system 6 and into the surrounding environment.
While making and using various embodiments of the present invention have been described in detail above, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention, and do not delimit the scope of the invention.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 63/086,301 filed on Oct. 1, 2020. The content of the aforementioned application is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
63086301 | Oct 2020 | US |